Search | PALTmed

News Release

October 14, 2025

Recommendations for COVID-19 Vaccine in PALTC Residents and Staff

PALTmed’s Infection Advisory Committee has developed recommendations for the 2025–2026 COVID-19 vaccine to guide clinicians and administrators in post-acute and long-term care settings. While the CDC provides national guidance, these recommendations address the specific risks and needs of PALTC residents a...

Podcast

August 29, 2024

PALTtalk | The Practical Two-Part Series | Navigating Access and Billing Challenges for COVID-19 Vaccine (Part 1 of 2)

Clinical Alerts

October 23, 2024

CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for People 65 Years and Older and for People Who are Moderately or Severely Immunocompromised

JAMDA

February 7, 2014

Promoting Positive Behavioral Health: A Non-pharmacologic Toolkit for Senior Living Communities

JAMDA

January 30, 2014

A New Toolkit for Behavioral Health

JAMDA

February 25, 2016

Caring for Patients Outside the Clinic: A Toolkit for Improving Quality and Efficiency

Caring for the Ages

June 30, 2018

Ready to Go: Guidelines and Toolkit for UTI Management

Caring for the Ages

March 2, 2015

AMDA Works With SHM on New Toolkit

Podcast

February 15, 2023

AMDA On-The-Go | February 2023 | Serious Illness Toolkit

JAMDA

January 11, 2022

Previous SARS-CoV-2 Infection, Age, and Frailty Are Associated With 6-Month Vaccine-Induced Anti-Spike Antibody Titer in Nursing Home Residents

Older nursing home residents make up the population at greatest risk of morbidity and mortality from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. No studies have examined the determinants of long-term antibody responses post vaccination in this group.